Back to Journals » Cancer Management and Research » Volume 14
Original Research
Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,106 | Dovepress* | 6,787+ | 328 | 7,115 | |
PubMed Central* | 319 | 120 | 439 | ||
Totals | 7,106 | 448 | 7,554 | ||
*Since 6 March 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed Central and Google Scholar